• About Us
    • Company History
    • Our Mission
    • Management Team
    • Board of Directors
  • Technology
    • The Problem
    • The Solution: Our Microbial Platforms
      • C1
      • Dapibus™
    • Advantages and Opportunities
  • Pipeline
    • Human Health
    • Animal Health
    • Alternative Proteins
  • Partners
  • Investors
    • Overview
    • Press Releases
    • SEC Filings
    • Financials
    • Investor Fact Sheet
    • Analyst Coverage
    • Corporate Governance
    • Annual Meeting and Proxy
    • Stock Information
    • Earnings Calls
    • Email Alert Opt-in
  • Media
    • Articles
    • Events
    • Presentations
    • Press Releases
    • Scientific Publications
    • Video Gallery
  • Contact Us

Sign up for communications from Dyadic

Stay informed and receive company updates straight to your inbox.

Signup

Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical and bio-industrial products for human and animal health and alternative proteins.

  • About Us
    • Company History
    • Our Mission
    • Management Team
    • Board of Directors
  • Technology
    • The Problem
    • The Solution: Our Microbial Platforms
      • C1
      • Dapibus™
    • Advantages and Opportunities
  • Pipeline
    • Human Health
    • Animal Health
    • Alternative Proteins
  • Partners
  • Investors
    • Overview
    • Press Releases
    • SEC Filings
    • Financials
    • Investor Fact Sheet
    • Analyst Coverage
    • Corporate Governance
    • Annual Meeting and Proxy
    • Stock Information
    • Earnings Calls
    • Email Alert Opt-in
  • Media
    • Articles
    • Events
    • Presentations
    • Press Releases
    • Scientific Publications
    • Video Gallery
  • Contact Us
© 2025 Dyadic International Inc